Google is the latest corporate to throw its weight behind Reliance Industries’ digital services spinoff whose shareholders already include Intel, Qualcomm and Facebook.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Auth0 accesses $120m series F
Salesforce Ventures led a $120m round for the identity management software provider that also attracted Deutsche Telekom and Telstra, at a valuation exceeding $1.9bn.
UiPath leads investors to $225m series E
The robotic process automation technology provider was valued at $10.2bn in a Tencent-backed round that lifted its overall funding to $1.3bn.
Beekeeper broadens series B to $60m
Swisscom and Swiss Post contributed to a $10m second extension that increased mobile communication software provider Beekeeper’s series B round to $60m.
SETsquared: a global leader continues to charge ahead
The world’s number one university incubator has been making a big impact since 2002, having supported more than 4,000 entrepreneurs that have raised more than $2.2bn between them.
Notarize contracts $35m in series C round
The online notary, whose backers include Lennar and Realogy Holdings, has raised $82m altogether, having revealed it closed funding in March.
Flipkart picks part of Arvind Youth Brands
Flipkart has paid $34.6m for a minority stake in Arvind Youth Brands as part of a strategic partnership to jointly explore market opportunities for its fashion apparel.
Harbour BioMed hoards $103m
The SK Holdings, China Life and Legend Holdings-backed cancer and inflammatory disease drug developer has now raised more than $260m in under two years.
Doctor on Demand prescribes $75m series D
General Atlantic led a $75m series D round for Doctor on Demand, a virtual care provider with shareholders including GV, Qualcomm Ventures and Dignify Health.
WBA moves into VillageMD with $250m
VillageMD is set to receive a total of $1bn in equity and convertible debt financing from Walgreens Boots Alliance over the next three years, giving the corporate a 30% stake.
BP books $70m for Green Growth Equity Fund
BP is set to invest $70m for the renewables-focused fund, which is managed by a joint venture of its Lightsource BP subsidiary and which has a target size of $700m.
Vor gets more in $110m series B
Stem-cell cancer treatment developer Vor Biopharma has collected more capital from investors including existing backers Johnson & Johnson and PureTech Health.
AlloVir approaches public markets
Gilead-backed AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.
LeanIX leaps into $80m series D
Software analysis product developer LeanIX has now secured $120m altogether, Deutsche Telekom Capital Partners returning for its latest funding.